These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8523234)

  • 21. Cases of neuroblastoma missed by the mass screening programs.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
    Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thoracic neuroblastoma].
    Lasson U
    Med Welt; 1980 Feb; 31(7):264-6. PubMed ID: 7366410
    [No Abstract]   [Full Text] [Related]  

  • 23. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
    Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
    Takeda T; Shimada M; Iizuka S; Takasugi N
    Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
    Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
    Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
    [No Abstract]   [Full Text] [Related]  

  • 26. False positive results in a neuroblastoma screening programme.
    Bell S; Parker L; Craft AW; Dale G; McGill AC; Seviour J; Cole M; Smith J
    Med Pediatr Oncol; 1994; 22(3):181-6. PubMed ID: 8272007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
    Woods WG; Tuchman M; Bernstein ML; Leclerc JM; Brisson L; Look T; Brodeur GM; Shimada H; Hann HL; Robison LL
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):312-9. PubMed ID: 1456396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Reliable chemical diagnosis of neuroblastoma better than screening.
    Bray PF; Wu JT; Myers GG
    N Engl J Med; 1976 Jul; 295(4):230-1. PubMed ID: 1272359
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.
    Kerbl R; Urban C; Starz I; Ambros IM; Strehl S; Kovar H; Gadner H; Ambros PF
    Med Pediatr Oncol; 1993; 21(9):625-6. PubMed ID: 8412992
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for neuroblastoma.
    Norman MG; Dimmick JE; Taylor GP; Teasdale M
    Lancet; 1987 Sep; 2(8558):565-6. PubMed ID: 2887853
    [No Abstract]   [Full Text] [Related]  

  • 31. Can a patient with neuroblastoma be diagnosed by a single urine sample collected randomly?
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Oncology; 1991; 48(1):31-3. PubMed ID: 1987496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass screening for neuroblastoma in infants.
    Wei M; Ye M; Dong K; Dong R
    Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of screening for neuroblastoma in the north of England.
    Craft AW; Parker L; Dale G; McGill AC; Seviour JA; Bell S; Cole M; Smith J
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):337-41. PubMed ID: 1456400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of neuroblastoma found by mass screening.
    Yamamoto K; Hanada R; Tanimura M; Aihara T; Hayashi Y
    Lancet; 1997 Apr; 349(9058):1102. PubMed ID: 9107271
    [No Abstract]   [Full Text] [Related]  

  • 37. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paracetamol interference with vanilmandelic and homovanillic acid quantification by the Bio-Rad HPLC kit].
    Drouard-Troalen L; Assicott MJ; Bonnay MM
    Ann Biol Clin (Paris); 2002; 60(5):626-7. PubMed ID: 12405118
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.